Drugs 13 , 43104330 (2015)
This very short action limited the initial enthusiasm for the possible usefulness of incretins for the treatment of T2DM, and in turn stimulated the development of both GLP1 agonists resistant to DPP-4, with a longer half-life and of DPP-4 inhibitors that prolong the half-life of native incretins
Presented for research literature review only Aldridge WN et al
A termk hatanyagai: 5% glutathion antioxidns, vdi a brt a szabad gykk kros hatsaitl, regedsgtl hats, kiegyenlti a br tnust, 5% niacinamid cskkenti a hiperpigmentcit s pigmentfoltokat, szablyozza a faggytermelst, tmogatja a br vdrtegt, antioxidns vdelmet nyjt, panthenol nyugtatja az irritcikat s a brprt, regenerlja s hidratlja a brt, puhv varzsolja azt, adenozin rnctalant hats, nveli a br feszessgt s rugalmassgt, hialuronsav intenzven hidratl, rugalmass s feszess teszi a brt